Asset profile
infliximab-dyyb · Castor Maritime Inc. (CTRM)
- Indication
- Crohn's disease and ulcerative colitis
- Also known as
- ZYMFENTRA, subcutaneous infliximab, SC infliximab
Company
CTRMCastor Maritime Inc.
CTRMCastor Maritime Inc.Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments, na…
On the calendar
Timeline
Newest first.
Registered trials
| Registry ID | Phase | Status | Primary completion | Enrollment | Sites |
|---|---|---|---|---|---|
| NCT06591273 | Phase 1/2 | Unknown | Nov 5, 2024 | 104 | 0 of 1 sites in the United States |
| NCT06059989 | Phase 3 | Recruiting | Jun 1, 2025 | 158 | 0 of 1 sites in the United States |
More from Castor Maritime Inc.
Other drugs and candidates from the same company tracked in this sector.